If you're taking or considering a GLP-1 medication for weight loss or blood sugar management, you've likely encountered three names: Ozempic, Mounjaro, and Wegovy. While they all belong to the GLP-1 drug class, they work differently at the molecular level, and these differences have real implications for your nutrition strategy. Let's break down what sets them apart and how to optimise your nutrition for each one.
Understanding the Medications
Before diving into the nutritional nuances, let's clarify what these medications actually are:
The Three Medications at a Glance
- Ozempic: Semaglutide for blood sugar management in type 2 diabetes. Uses GLP-1 mechanism.
- Wegovy: Also semaglutide, but formulated and approved specifically for weight loss in non-diabetic patients.
- Mounjaro: Tirzepatide, a newer dual-action medication that targets both GLP-1 and GIP receptors.
The key distinction: Ozempic and Wegovy use the same active ingredient (semaglutide), just with different indications. Mounjaro is an entirely different compound with a different mechanism of action, and that matters for how your body responds to food and nutrients.
The Science: Semaglutide vs Tirzepatide
Understanding the molecular difference helps explain why your nutrition needs might vary slightly:
GLP-1 Only (Ozempic/Wegovy)
Semaglutide activates GLP-1 receptors, which slow gastric emptying, increase feelings of fullness, and improve blood sugar control. It's a proven, well-studied mechanism that's been around longer.
GLP-1 + GIP (Mounjaro)
Tirzepatide works on two receptor systems: GLP-1 and GIP. What that means for any one person is a question for their prescriber, not for us. The GIP component adds another layer to how your body processes food and manages energy.
The choice between these medications should always involve your healthcare provider. This comparison is educational and doesn't replace medical advice.
Weight Loss: What to Watch
How much weight comes off, and how fast, is between you and your prescriber. We do not compare medications on it and we do not publish a figure for it. What we do watch is what the loss is made of, and that is the same question whichever one you are on:
- Ozempic/Wegovy (semaglutide): Watch the pace, not the total. Our coaching rule of thumb is that more than about 1% of body weight a week for several weeks running is worth raising with your prescriber.
- Mounjaro (tirzepatide): Watch the same number, and watch the strength test alongside it. Pooled across 20 randomised trials, 25.4% of the weight lost on tirzepatide was lean mass, against 26.2% when the same weight came off by diet alone and 17.5% when resistance training was added.
Individual results vary widely. Starting weight, adherence, activity level and diet quality matter as much as anything else, and the protein and the two strength sessions are the part you control.
Appetite Suppression: Key Differences
All GLP-1 medications reduce appetite, but the quality of suppression differs:
Appetite Suppression Profiles
- Semaglutide (Ozempic/Wegovy): Produces steady appetite reduction and delayed gastric emptying. Users often report thinking about food less frequently.
- Tirzepatide (Mounjaro): The dual GLP-1/GIP mechanism may create more pronounced fullness signals. Some users report faster satiety (feeling full sooner in a meal).
From a nutrition standpoint, what matters is the size of the window you have to work with. Some people find portions shrink sharply and need protein by the clock; others keep more flexibility with moderate portions. Work with the appetite you actually have this week rather than the one the label describes.
Side Effects: Nausea and GI Considerations
Nausea is the most common side effect, and it varies by medication:
- Semaglutide: Nausea typically peaks in the first 2-4 weeks and diminishes as the body adjusts. It affects 25-40% of users.
- Tirzepatide: Slightly higher initial nausea rates (30-45%), possibly due to the dual receptor activation. However, some users report it resolves faster.
Nutrition impact: Nausea affects what you can tolerate. Semaglutide users often do better with lighter, blander foods initially. Tirzepatide users might experience more pronounced food aversions in the weeks just after each step up.
Nutritional Considerations by Medication
Here's where personalisation matters most. While all GLP-1 medications require adequate nutrition, each one has specific considerations:
For Ozempic/Wegovy Users
- Meal timing: Slower gastric emptying means you feel full longer, spacing meals 4-5 hours apart often works well.
- Nausea management: Focus on protein-rich foods that are bland (chicken, fish, eggs, Greek yoghurt) during the first month.
- Fluid intake: Easy to forget to drink water when not hungry; aim for 2-3 litres daily to prevent constipation.
- Electrolytes: Include sodium and potassium-rich foods (leafy greens, broth, avocado) to maintain balance.
For Mounjaro Users
- Portion control: The dual action may make large portions uncomfortable. Eat smaller amounts more frequently if needed.
- Nausea strategy: Similar to semaglutide, but monitor for longer-lasting aversions to specific foods.
- Meal composition: Balanced meals with protein, fat, and fibre help with satiety without overwhelming a smaller appetite.
- Hydration and bowel health: Same emphasis as semaglutide. GI effects are real.
Protein Needs: The Same Across All GLP-1s
Here's the crucial point: protein requirements don't change based on which GLP-1 you take. All users need 1.2-2.2 grams of protein per kilogram of body weight daily to preserve muscle mass during weight loss. This is non-negotiable.
The medication difference isn't about needing more or less protein, it's about how you achieve that protein intake given reduced appetite:
- Prioritise high-protein foods at each meal (lean meats, fish, eggs, legumes, dairy).
- Use protein shakes to bridge gaps if solid food feels unappetising.
- Time protein intake around workouts to support muscle recovery.
Falling short on protein on GLP-1s leads to muscle loss, which slows metabolism and undermines long-term weight management success.
Micronutrient Absorption and Deficiency Risk
GLP-1 medications slow gastric emptying and reduce overall food intake, which can affect nutrient absorption:
- B12: Delayed gastric emptying may reduce intrinsic factor-mediated B12 absorption. Worth asking your GP whether yours should be monitored.
- Iron: Reduced stomach acid exposure (from slower emptying) may impair iron absorption. Pair iron-rich foods with vitamin C.
- Calcium and vitamin D: Reduced dairy intake due to appetite suppression can compromise bone health. Keep the food sources up, and let your GP decide whether you need anything beyond that.
- Fibre: While you eat less, you need adequate fibre for gut health. Include vegetables, legumes, and whole grains proportionally.
Neither medication choice changes this, it's a general GLP-1 consideration. Regular blood work can identify deficiencies early.
How EverStrong Adapts Your Nutrition to Your Medication
At EverStrong, we know that GLP-1 success isn't one-size-fits-all. Our nutrition coaching adjusts to your specific medication:
Personalised for Your GLP-1
- If you're on semaglutide (Ozempic/Wegovy), we suggest meal timing and food combinations that work with slower gastric emptying.
- If you're on tirzepatide (Mounjaro), we tailor portion sizes to the appetite you report, meal by meal.
- For all users, we ensure protein targets are met despite reduced appetite, and we monitor for nutritional gaps.
- We adapt as your body adjusts, week 1 nausea strategies differ from week 8 approaches.
The goal is simple: maximise the effectiveness of your medication while protecting your health and building sustainable eating habits.
Key Takeaways
- Ozempic and Wegovy are the same drug (semaglutide) with different approved uses; they work via GLP-1 receptors alone.
- Mounjaro (tirzepatide) adds a GIP component. Whether that suits you is your prescriber's call, not ours.
- Weight loss differences are modest, 15-24%, and individual response varies more than medication choice.
- Nausea and side effects differ slightly but follow similar timelines across medications.
- Protein and micronutrient needs are the same for all GLP-1s, don't skip them despite reduced appetite.
- Personalised nutrition coaching that accounts for your specific medication dramatically improves outcomes.
Important Disclaimer: This article is for educational purposes only. It does not constitute medical advice. The choice between GLP-1 medications should be made in consultation with your healthcare provider based on your individual health status, goals, and medical history. Always follow your doctor's guidance regarding medication selection and dosing.
Ready to Optimise Your Nutrition?
Whether you're on Ozempic, Wegovy, or Mounjaro, the right nutrition strategy multiplies your medication's effectiveness. EverStrong's coaching adapts to your specific GLP-1, your preferences, and your goals, making sustainable weight loss and health real, not theoretical.